Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Genetic Disease
Macular Degeneration Clinical Trials
A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Peoria : Retina Consultants of Arizona
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Phoenix : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Phoenix : Associated Retina Consultants
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Phoenix : Retina Consultants of Arizona
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Phoenix : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
View More »
Phoenix :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Phoenix : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Phoenix :
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
Phoenix : Retina Consultants of Arizona
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Phoenix :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Scottsdale : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Tucson : Retina Associates SW
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Tucson : Retina Centers, P.C.
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Tucson : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Tucson : Novartis Investigative Site
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
California
Arcadia :
A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration
Arcadia : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Arcadia : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Bakersfield : California Retina Consultants
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Bakersfield : California Retinal Consultants
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
View More »
Beverly Hills : Retina-Vitreous Associates
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Beverly Hills : Retina-Vitreous Associates Medical Group
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Beverly Hills : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Beverly Hills : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Beverly Hills :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Campbell : Retinal Diagnostic Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Encinitas : Morris Eye Group
Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)
Irvine : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
La Jolla : Shiley Eye Center, UCSD
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
La Jolla : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Laguna Hills : Retina Associates of Orange County
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Los Angeles : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Los Angeles : Jules Stein Eye Institute, UCLA School of Medicine
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Los Angeles : Jules Stein Eye Institute/UCLA
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Los Angeles : Jules Stein Eye Institute, UCLA School of Medicine
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Marietta : Marietta Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Mountain View : Northern California Retina Vitreous Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Mountain View : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Oakland : East Bay Retina
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography
Oakland :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Palm Desert :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Palo Alto : Byers Eye Institute at Stanford, Stanford Hospital and Clinics Updated
Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Rancho Mirage : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sacramento : Retinal Consultants Medical Group, Inc.
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Sacramento : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sacramento : University of California, Davis
Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) - Correlation With Lucentis(R) Therapy
Sacramento :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
San Francisco : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
San Francisco : Pacific Eye Associates
Genetic Load and Phenotype in Aggressive AMD
San Francisco : West Coast Retina
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography
Santa Ana : Orange County Retina Medical Group
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Santa Ana : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Santa Ana :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Santa Barbara : California Retina Consultants
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
Torrance : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Ventura : Miramar Eye Specialists
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Westlake Village :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Colorado
Colorado Springs :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Golden : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Golden : Colorado Retina
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Golden :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Connecticut
New London : New England Retina Associates
Pilot Study of X-82 in Patients With Wet AMD
Florida
Altamonte Springs : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Boynton Beach : Florida Eye Microsurgical Institute Inc.
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Boynton Beach : Florida Eye Microsurgical Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Boynton Beach :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Fort Lauderdale : Retina Group of Florida
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
View More »
Fort Lauderdale :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Fort Myers : Retina Health Center
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Fort Myers : Retina Health Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Fort Myers : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Fort Myers :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Miami : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Miami : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Miami : Bascom Palmer Eye Institute
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography
Miami : Bascom Palmer Eye Institute
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Miami : Bascom Palmer Eye institute
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Orlando : Magruder Eye Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Palm Beach Gardens : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Pensacola : Retina Specialty Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Pensacola :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Plantation : Fort Lauderdale Eye Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Plantation :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Stuart : East Florida Eye Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Tampa : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Tampa :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Winter Haven : Center for Retina & Macular Disease
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Winter Haven : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Winter Haven : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Georgia
Atlanta : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Augusta : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Augusta : Southeast Retina Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Augusta : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Augusta : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
View More »
Augusta :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Illinois
Chicago : University of Chicago Medica Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Indiana
Indianapolis : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Indianapolis : Midwest Eye Institute
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Indianapolis : Midwest Eye Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Indianapolis : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
New Albany : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
View More »
New Albany :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Iowa
Marshalltown : Wolfe Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
West Des Moines : Wolfe Eye Clinic
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Kansas
Leawood : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Mission : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Overland Park : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Wichita : Central Plains Eye MDs
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Wichita :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Kentucky
Lexington : Retina Associates of Kentucky
Genetic Load and Phenotype in Aggressive AMD
Lexington :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Louisville : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Louisville : Bennett & Bloom Eye Centers
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Paducah : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Maine
Portland : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Maryland
Baltimore : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Baltimore : Elman Retina
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Baltimore : Johns Hopkins Unversity
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Baltimore : Johns Hopkins University Hospital
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Baltimore : Elman Retina Group
Pilot Study of X-82 in Patients With Wet AMD
View More »
Baltimore : Johns Hopkins University School of Medicine
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Hagerstown : Cumberland Valley Retina Consultants
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Towson : Retina Specialists
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Towson : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Massachusetts
Boston : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Boston : Ophthalmic Consultants of Boston
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Boston : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Boston : Mass Eye and Ear
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Boston : Ophthalmic Consultants of Boston
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
View More »
Boston : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Boston :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Worcester : University of Massachusetts Medical School
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Worcester :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Michigan
Ann Arbor : University of Michigan
Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration
Detroit : Henry Ford Health System
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Detroit : Kresge Eye Institute
Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
Grand Rapids : Vision Research Foundation
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Grand Rapids : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
View More »
Jackson : TLC Eye Care and Laser Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Lansing : TLC Eyecare and Laser Centers
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography
Royal Oak : Vision Research Foundation
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Southfield : Retina Consultants of Michigan
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Traverse City : Vision Research Foundation
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Missouri
Kansas City : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
St. Louis : The Retina Center
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
St. Louis : Barnes Retina Institute
Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD
Nebraska
Lincoln :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Nevada
Las Vegas :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
New Hampshire
Portsmouth :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
New Jersey
Cherry Hill : Mid Atlantic Retina- Cherry Hill
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Lawrenceville : Delaware Valley Retina Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Lawrenceville :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
New Brunswick : Total Practice Management
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
New Brunswick : Retina Vitreous Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
View More »
Newark : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Northfield : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Northfield :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Teaneck :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Toms River : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
New York
Brooklyn : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Lynbrook : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
New York : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
New York : Macula Care
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
New York : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
View More »
New York : New York Eye and Ear Infirmary
Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy
Rochester :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Rockville Centre : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Shirley : Island Retina
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
North Carolina
Additional Locations : Theragenics Clinical Site
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Asheville :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Charlotte : Charlotte Eye Ear Nose & Throat Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Charlotte : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Ohio
Additional Locations : Novartis Investigative Site
Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Cincinnati : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Cleveland : Retina Associates of Cleveland
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Cleveland : Cole Eye Institute, Cleveland Clinic
Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Injection in Subjects With Exudative Macular Degeneration Previously Treated With Ranibizumab or Bevacizumab
Oklahoma
Oklahoma City :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Tulsa : Eagle Mountain Vision
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
Oregon
Ashland : Retina & Vitreous Center SO
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Ashland : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Portland : Dr Andreas Lauer
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Portland : Casey Eye Institute, Oregon Health & Science University
Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration
Portland :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
View More »
Salem :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Pennsylvania
Camp Hill : PA Retina
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Camp Hill : Pennsylvania Retina Specialists
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Huntingdon Valley : Mid Atlantic Retina- Huntingdon Valley
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Kingston :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Philadelphia :
A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration
View More »
Philadelphia : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Philadelphia : Mid Atlantic Retina- Wills Eye Institute
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
Philadelphia : Wills Eye Institute-Mid Atlantic Retina
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Philadelphia : Wills Eye Institute-Mid Atlantic Retina
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Pittsburgh :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
West Mifflin : Associates in Ophthalmology
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
West Mifflin : Associates in Ophthalmology
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
South Carolina
Florence :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Ladson : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
West Columbia : Palmetto Retina Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
West Columbia : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
West Columbia :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
View More »
West Columbia : Palmetto Retina Center
Treat and Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
South Dakota
Rapid City : Black Hills Regional Eye Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Rapid City :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Tennessee
Nashville : TN Retina
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Nashville : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Nashville : Tennessee Retina
Genetic Load and Phenotype in Aggressive AMD
Nashville :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Texas
Abilene : Retina Research Institute of Texas, LLC
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
Abilene : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Abilene : Retina Research Institute of Texas
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Abilene : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Arlington : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
View More »
Arlington :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Austin : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Austin : Retina Research Center
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Austin : Austin Retina Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Austin : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Dallas : Texas Retina Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Dallas : Retina Foundation of the Southwest Updated
Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
Efficacy and Safety Study of ESBA1008 Versus EYLEA®
Fort Worth :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Galveston : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Harlingen : Valley Retina Institute
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Harlingen : Valley Retina Institute
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Houston : Retina Consultants of Houston
Pilot Study of X-82 in Patients With Wet AMD
Houston :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Houston : Retina Consultants of Houston/The Medical Center
Treat and Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Katy : Retina Consultants of Houston/Katy office
Treat and Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
McAllen : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
McAllen : Valley Retina Institute
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
San Antonio : Medical Center Ophthalmology Associates
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab.
San Antonio : Medical Center Ophthalmology Associates
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
San Antonio : Retina Associates of South Texas
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
San Antonio : Medical Center Ophthalmology Associates
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
San Antonio : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
San Antonio :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
The Woodlands : Retina Consultants of Houston
Treat and Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Utah
Salt Lake City : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Salt Lake City : Rocky Mountain Retina Consultants
Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD)
Virginia
Charlottesville : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Washington
Seattle : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Seattle :
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Wisconsin
Madison : University of Wisconsin
Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)
Argentina
Buenos Aires : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Rosario : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Australia
Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Brisbane : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
East Melbourne : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Fitzroy : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Forster : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Hobart : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Kogarah : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Nedlands : Lions Eye Institute
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
North Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Parramatta : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
South Launceston : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Strathfield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Sydney :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Sydney : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Westmead : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Austria
Vienna :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Belgium
Bonheiden : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Hasselt : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Leuven : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Brazil
Goiania : Universidade Federal de Goias
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).
Bulgaria
Sofia : Multiple Investigators
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Canada
London Ontario : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Miramichi : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Mississauga : GSK Investigational Site
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Mississauga : Canadian Centre for Advanced Eye Therapeutics Inc.
HELP Therapy for Dry AMD
China
Beijing :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Changsha :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Chengdu :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Chongqing : Novartis Investigative Site
Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)
Guangzhou :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
View More »
Hangzhou :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Nanchang : Novartis Investigative Site
Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)
Qingdao : Novartis Investigative Site
Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)
Qingdao :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Shanghai : Novartis Investigative Site
Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)
Shanghai :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Tianjin :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Wenzhou :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Xi'an :
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
Czech Republic
Brno-Bohunice, Olomouc, Praha : Multiple Investigators
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
France
Créteil :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Lille : Institut Pasteur de Lille
Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment
Paris : Centre Hospitalier Nationale d'Ophthalmologie des Quinze-Vingts
Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration
Germany
Bonn :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Ludwigshafen : Department of Ophthalmology, Ludwigshafen hospital
Subretinal Macugen® for Neovascular Age-Related Macular Degeneration
Many Locations :
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany
Israel
Ashkelon : Barzilai Medical Center
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Haifa : Carmel Medical Center
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Jerusalem : Hadassah Medical center Israel
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Tel Aviv :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Tel Hasomer : Sheba Medical Center
Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
View More »
Tel-Aviv : Tel-Aviv Sourasky Medical Center
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Zefat : Ziv Medical Center
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Italy
Firenze :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Japan
Many Locations :
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
Many Locations :
EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan
Korea, Republic of
Seongnam-si : CHA Bundang Medical Center
A Phase I/IIa, Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial(MA09-hRPE) Cells in Patients With Advanced Dry Age-related Macular Degeneration(AMD)
Seongnam-si : CHA Bundang Medical Center
Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
Mexico
Mexico City : APEC Hospital La Ceguera
A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Netherlands
Tilburg : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Poland
Warsaw, Bydgoszcz, Lubin : Multiple Investigators
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Romania
Bucharest : Multiple Investigators
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Singapore
Singapore : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Switzerland
Binningen :
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
United Kingdom
Bolton : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
County Durham : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Edinburgh : NHS Lothian Princess Alexandra Eye Pavillion
Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Essex : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
London : Moorefields Eye Hospital NHS Foundation Trust
Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
View More »
Manchester : Manchester Royal Eye Hospital
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Manchester : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norfolk : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Sheffield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Southampton : Pfizer Investigational Site
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Stoke on Trent : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Surrey : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting